Trial
NCT03993457
Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
Depression
Intervention
Escitalopram
Why stopped
terminated during COVID due to inability to see participants in person.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-18